RxDoctor Payments Data

Emily Prevo, DO

Family Medicine · Zeeland, MINPI 1538696034

Payments from drug & device makers

$502in general payments, 2019–2025

Across 19 payments — averaging $26.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$158
  • AstraZeneca$110
  • Pfizer$76
  • Otsuka America Pharmaceutical, Inc.$60
  • Novo Nordisk$34
  • Neurocrine Biosciences, Inc.$19
  • plus $45 from 4 others

What the payments were for

  • Food & beverage$502100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$502 in reported general payments places this provider in the 60th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$4,910
Medicare patients
27
Services billed
76

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin59$52,198
Trelegy ElliptaFluticasone/Umeclidin/Vilanter30$23,007
EliquisApixaban24$19,493
TrulicityDulaglutide13$12,427
MounjaroTirzepatide11$11,332
LinzessLinaclotide11$5,678
Atorvastatin Calcium156$2,180
Levothyroxine Sodium126$1,376
Losartan Potassium65$1,002
Lisinopril72$898
Duloxetine Hcl25$811
Dicyclomine Hcl27$767
Bupropion XlBupropion Hcl30$732
Omeprazole50$728
Amlodipine Besylate95$720

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$11$52,19859 claims
PfizerEliquis$76$19,49324 claims
AbbVieLinzess$15$5,67811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Zeeland

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →